U.S. Cold Chain Packaging Solutions for Biologics
The pharmaceutical cold chain packaging industry in the United States is poised for significant expansion, with its market value projected to grow from USD 4.9 billion in 2025 to USD 13.8 billion by 2035 . This represents a robust Compound Annual Growth Rate (CAGR) of 10.9% over the forecast period, driven by the critical need for temperature-controlled solutions to transport sensitive drugs, biologics, and vaccines. Browse the Complete Report: https://www.futuremarketinsights.com/reports/pharmaceutical-cold-chain-packaging-industry-analysis-in-united-states This growth is a direct response to the increasing development of high-value, temperature-sensitive pharmaceuticals and the need for validated logistics. The market, which accounts for a 4-6% share of the pharmaceutical packaging space, is a vital link in the drug supply chain. Recent strategic moves, such as Knipper Health’s acquisition of Thermo Fisher Scientific’s commercial sample management operations in Memphis, ...